TherapeuticsMD (TXMD) Treasury Shares (2013 - 2026)
TherapeuticsMD (TXMD) posted Treasury Shares of $26000.0 for Q1 2026, little changed on a QoQ basis from $26000.0 in Q4 2025, and up 420.0% year-over-year from $5000.0 in Q1 2025.
TherapeuticsMD (TXMD) Treasury Shares (2013 - 2026) Analysis & Trends
TherapeuticsMD's Treasury Shares history runs 11 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- Quarterly Treasury Shares rose 420.0% year-over-year to $26000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26000.0 (up 420.0% YoY) and the FY2025 annual result came in at $26000.0, changed 0.0% from the prior year.
- Treasury Shares was $26000.0 for Q1 2026 at TherapeuticsMD, roughly flat from $26000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $100000.0 in Q3 2022 and bottomed at $5.0 in Q1 2024.
- A 5-year average of $32067.0 and a median of $26000.0 in 2024 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares tumbled 99.97% — and 2025, when it soared 99900.0%.
- TherapeuticsMD's Treasury Shares stood at $19000.0 in 2022, then surged by 110.53% to $40000.0 in 2023, then slumped by 35.0% to $26000.0 in 2024, then changed by 0.0% to $26000.0 in 2025, then changed by 0.0% to $26000.0 in 2026.
- Business Quant data shows TXMD's Treasury Shares at $26000.0 in Q1 2026, $26000.0 in Q4 2025, and $5000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | 26,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 38,000.00 |
| Mar 31, 2024 | 5.00 |
| Mar 31, 2024 | 5.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Sep 30, 2023 | 84,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 70,000.00 |